{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T12:46:44Z","timestamp":1790858804538,"version":"4.1.0"},"reference-count":91,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2019,3,1]],"date-time":"2019-03-01T00:00:00Z","timestamp":1551398400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,3,1]],"date-time":"2019-03-01T00:00:00Z","timestamp":1551398400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jem-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Emergency Medicine"],"published-print":{"date-parts":[[2019,3]]},"DOI":"10.1016\/j.jemermed.2018.12.010","type":"journal-article","created":{"date-parts":[[2019,1,30]],"date-time":"2019-01-30T09:45:07Z","timestamp":1548841507000},"page":"308-318","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"title":["Esmolol Compared with Amiodarone in the Treatment of Recent-Onset Atrial Fibrillation (RAF): An Emergency Medicine External Validity Study"],"prefix":"10.1016","volume":"56","author":[{"given":"Kolia","family":"Milojevic","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandra","family":"Beltramini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohsen","family":"Nagash","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandre","family":"Muret","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivier","family":"Richard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yves","family":"Lambert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jemermed.2018.12.010_bib1","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1111\/acem.12016","article-title":"An international view of how recent-onset atrial fibrillation is treated in the emergency department","volume":"19","author":"Rogenstein","year":"2012","journal-title":"Acad Emerg Med"},{"issue":"suppl 1","key":"10.1016\/j.jemermed.2018.12.010_bib2","first-page":"22","article-title":"Assessment of baseline characteristics and risk factors among Emergency Department patients presenting with recent onset atrial fibrillation: a retrospective cohort study","volume":"17","author":"Buccelletti","year":"2013","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"10.1016\/j.jemermed.2018.12.010_bib3","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1016\/j.annemergmed.2013.06.005","article-title":"A population-based description of atrial fibrillation in the emergency department, 2002 to 2010","volume":"62","author":"Atzema","year":"2013","journal-title":"Ann Emerg Med"},{"key":"10.1016\/j.jemermed.2018.12.010_bib4","first-page":"210","article-title":"Atrial fibrillation (acute onset)","volume":"5","author":"Lip","year":"2008","journal-title":"BMJ Clin Evid"},{"key":"10.1016\/j.jemermed.2018.12.010_bib5","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.jemermed.2010.05.017","article-title":"Managing emergency department patients with recent-onset atrial fibrillation","volume":"42","author":"Vinson","year":"2012","journal-title":"J Emerg Med"},{"key":"10.1016\/j.jemermed.2018.12.010_bib6","doi-asserted-by":"crossref","first-page":"2893","DOI":"10.1093\/eurheartj\/ehw210","article-title":"Guidelines for the management of atrial fibrillation developed in collaboration with EACTS","volume":"37","author":"Kirchhof","year":"2016","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jemermed.2018.12.010_bib7","doi-asserted-by":"crossref","first-page":"2369","DOI":"10.1093\/eurheartj\/ehq278","article-title":"Guidelines for the management of atrial fibrillation: the Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC)","volume":"31","author":"Camm","year":"2010","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jemermed.2018.12.010_bib8","first-page":"38","article-title":"Canadian Cardiovascular Society atrial fibrillation guidelines 2010: management of recent-onset atrial fibrillation and flutter in the emergency department","volume":"27","author":"Stiell","year":"2011","journal-title":"Can J Cardiol"},{"key":"10.1016\/j.jemermed.2018.12.010_bib9","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1016\/j.ijcard.2015.10.220","article-title":"Atrial fibrillation and heart failure due to reduced versus preserved ejection fraction: a systematic review and meta-analysis of death and adverse outcomes","volume":"203","author":"Kotecha","year":"2016","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.jemermed.2018.12.010_bib10","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1093\/europace\/eut263","article-title":"Management of atrial fibrillation in seven European countries after the publication of the 2010 ESC Guidelines on atrial fibrillation: primary results of the PREvention oF thromboembolic events-European registry in Atrial Fibrillation (PREFER in AF)","volume":"16","author":"Kirchhof","year":"2014","journal-title":"Eurospace"},{"key":"10.1016\/j.jemermed.2018.12.010_bib11","first-page":"1170","article-title":"2016 Focused update of the Canadian cardiovascular Society guidelines for the management of atrial fibrillation","volume":"32","author":"Macle","year":"2016","journal-title":"Can J Cardiol"},{"key":"10.1016\/j.jemermed.2018.12.010_bib12","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.annemergmed.2010.05.031","article-title":"A clinical prediction model to estimate risk for thirty day adverse events in emergency department patients with symptomatic atrial fibrillation","volume":"57","author":"Barrett","year":"2011","journal-title":"Ann Emerg Med"},{"key":"10.1016\/j.jemermed.2018.12.010_bib13","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/j.hlc.2010.01.009","article-title":"Management of atrial fibrillation in the acute setting--findings from an Australasian survey","volume":"19","author":"Arendts","year":"2010","journal-title":"Heart Lung Circ"},{"key":"10.1016\/j.jemermed.2018.12.010_bib14","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1016\/j.ajem.2009.12.016","article-title":"A 2-year survey of treatment of acute atrial fibrillation in an ED","volume":"29","author":"Hirschl","year":"2011","journal-title":"Am J Emerg Med"},{"key":"10.1016\/j.jemermed.2018.12.010_bib15","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.jemermed.2013.01.027","article-title":"Is emergency department cardioversion of recent-onset atrial fibrillation safe and effective?","volume":"45","author":"Cohn","year":"2013","journal-title":"J Emerg Med"},{"key":"10.1016\/j.jemermed.2018.12.010_bib16","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1136\/emj.2004.021055","article-title":"Biphasic cardioversion of acute atrial fibrillation in the emergency department","volume":"23","author":"Lo","year":"2006","journal-title":"Emerg Med J"},{"key":"10.1016\/j.jemermed.2018.12.010_bib17","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/j.annemergmed.2007.12.015","article-title":"A prospective, randomized trial of an emergency department observation unit for acute onset atrial fibrillation","volume":"525","author":"Deckert","year":"2008","journal-title":"Ann Emerg Med"},{"key":"10.1016\/j.jemermed.2018.12.010_bib18","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1111\/j.1553-2712.2010.00697.x","article-title":"Thirty-day outcomes of emergency department patients undergoing electrical cardioversion for atrial fibrillation or flutter","volume":"17","author":"Scheuermeyer","year":"2010","journal-title":"Acad Emerg Med"},{"key":"10.1016\/j.jemermed.2018.12.010_bib19","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1002\/clc.20268","article-title":"Successful conversion of recent-onset atrial fibrillation by sequential administration of up to three antiarrhythmic drugs","volume":"31","author":"Milicevic","year":"2008","journal-title":"Clin Cardiol"},{"key":"10.1016\/j.jemermed.2018.12.010_bib20","first-page":"125","article-title":"Focused 2012 update of the Canadian Cardiovascular Society Atrial Fibrillation Guidelines: recommendations for stroke prevention and rate\/rhythm control","volume":"28","author":"Skanes","year":"2012","journal-title":"Can J Cardiol"},{"key":"10.1016\/j.jemermed.2018.12.010_bib21","first-page":"2071","article-title":"2014 AHA\/ACC\/HRS guideline for the management of patients with atrial fibrillation: executive summary: a report of the American College of Cardiology\/American Heart Association Task Force on practice guidelines and the Hearth Rhythm Society","volume":"130","author":"January","year":"2014","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jemermed.2018.12.010_bib22","doi-asserted-by":"crossref","first-page":"2719","DOI":"10.1093\/eurheartj\/ehs253","article-title":"2012 focused update of the ESC Guidelines for the management of atrial fibrillation","volume":"33","author":"Camm","year":"2012","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jemermed.2018.12.010_bib23","doi-asserted-by":"crossref","first-page":"e257","DOI":"10.1161\/circ.114.4.257","volume":"114","author":"Fuster","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/j.jemermed.2018.12.010_bib24","doi-asserted-by":"crossref","first-page":"1919","DOI":"10.1093\/europace\/euy039","article-title":"Major knowledge gaps and system barriers to guideline implementation among European physicians treating patients with atrial fibrillation: a European Society of Cardiology international educational needs assessment","volume":"20","author":"Heidbuchel","year":"2018","journal-title":"Europace"},{"key":"10.1016\/j.jemermed.2018.12.010_bib25","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1016\/j.ajem.2010.03.021","article-title":"Low-dose diltiazem in atrial fibrillation with rapid ventricular response","volume":"29","author":"Lee","year":"2011","journal-title":"Am J Emerg Med"},{"key":"10.1016\/j.jemermed.2018.12.010_bib26","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1016\/S0735-6757(97)90141-8","article-title":"Dilemmas in the acute pharmacological treatment of uncontrolled atrial fibrillation","volume":"15","author":"Elam","year":"1997","journal-title":"Am J Emerg Med"},{"key":"10.1016\/j.jemermed.2018.12.010_bib27","doi-asserted-by":"crossref","first-page":"S15","DOI":"10.1067\/mhj.2001.109952","article-title":"Pharmacologic management of atrial fibrillation: current therapeutic strategies","volume":"141","author":"Levy","year":"2001","journal-title":"Am Heart J"},{"key":"10.1016\/j.jemermed.2018.12.010_bib28","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1111\/anae.12050","article-title":"Medical emergencies: atrial fibrillation and myocardial infarction","volume":"68","author":"Somasundaram","year":"2013","journal-title":"Anaesthesia"},{"key":"10.1016\/j.jemermed.2018.12.010_bib29","first-page":"249","article-title":"Acute management of atrial fibrillation","volume":"66","author":"King","year":"2002","journal-title":"Am Fam Physician"},{"key":"10.1016\/j.jemermed.2018.12.010_bib30","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.ijcard.2003.08.006","article-title":"Acute ventricular rate control in atrial fibrillation and atrial flutter","volume":"97","author":"Khan","year":"2004","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.jemermed.2018.12.010_bib31","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1177\/1074248407303792","article-title":"Conversion of atrial fibrillation to sinus rhythm during treatment with intravenous esmolol or diltiazem: a prospective, randomized comparison","volume":"12","author":"Hassan","year":"2007","journal-title":"J Cardiovasc Pharmacol Ther"},{"key":"10.1016\/j.jemermed.2018.12.010_bib32","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1097\/00000542-199811000-00004","article-title":"Beta-adrenergic blockade accelerates conversion of postoperative supraventricular tachyarrhythmias","volume":"89","author":"Balser","year":"1998","journal-title":"Anesthesiology"},{"key":"10.1016\/j.jemermed.2018.12.010_bib33","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1177\/107424840200700204","article-title":"Effects of diltiazem and esmolol on cycle length and spontaneous conversion of atrial fibrillation","volume":"7","author":"Sticherling","year":"2002","journal-title":"J Cardiovasc Pharmacol Ther"},{"key":"10.1016\/j.jemermed.2018.12.010_bib34","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1016\/j.athoracsur.2011.06.104","article-title":"The Society of Thoracic Surgeons practice guideline on the prophylaxis and management of atrial fibrillation associated with general thoracic surgery: executive summary","volume":"92","author":"Fernando","year":"2011","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.jemermed.2018.12.010_bib35","doi-asserted-by":"crossref","first-page":"1935","DOI":"10.1016\/j.jacc.2013.02.001","article-title":"Management of patients with atrial fibrillation (compilation of 2006 ACCF\/AHA\/ESC and 2011 ACCF\/AHA\/HRS recommendations): a report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines","volume":"61","author":"Anderson","year":"2013","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jemermed.2018.12.010_bib36","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1093\/europace\/euq450","article-title":"Mixed treatment comparison of dronedarone, amiodarone, sotalol, flecainide, and propafenone, for the management of atrial fibrillation","volume":"13","author":"Freemantle","year":"2011","journal-title":"Eurospace"},{"key":"10.1016\/j.jemermed.2018.12.010_bib37","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1017\/S1481803500007922","article-title":"Intravenous amiodarone for acute pharmacological conversion of atrial fibrillation in the emergency department","volume":"4","author":"Slavik","year":"2002","journal-title":"CJEM"},{"key":"10.1016\/j.jemermed.2018.12.010_bib38","doi-asserted-by":"crossref","first-page":"1825","DOI":"10.1056\/NEJMoa021328","article-title":"A comparison of rate control and rhythm control in patients with atrial fibrillation","volume":"347","author":"Wyse","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jemermed.2018.12.010_bib39","doi-asserted-by":"crossref","first-page":"302","DOI":"10.2174\/157340312803760785","article-title":"Novel anti-arrhythmic medications in the treatment of atrial fibrillation","volume":"8","author":"Saklani","year":"2012","journal-title":"Curr Cardiol Rev"},{"key":"10.1016\/j.jemermed.2018.12.010_bib40","first-page":"12","article-title":"Medical rate control in atrial fibrillation","volume":"25","author":"Nabauer","year":"2014","journal-title":"Herzschrittmacherther Elektrophysiol"},{"key":"10.1016\/j.jemermed.2018.12.010_bib41","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1159\/000355312","article-title":"A low-dose \u03b21-blocker effectively and safely slows the heart rate in patients with acute decompensated heart failure and rapid atrial fibrillation","volume":"127","author":"Kobayashi","year":"2014","journal-title":"Cardiology"},{"key":"10.1016\/j.jemermed.2018.12.010_bib42","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1253\/circj.CJ-12-1618","article-title":"Urgent management of rapid heart rate in patients with atrial fibrillation\/flutter and left ventricular dysfunction: comparison of the ultra-short-acting \u03b21-selective blocker landiolol with digoxin (J-land Study)","volume":"77","author":"Nagai","year":"2013","journal-title":"Circ J"},{"key":"10.1016\/j.jemermed.2018.12.010_bib43","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1038\/clpt.1985.23","article-title":"Antiarrhythmic effects of ointravenous timolol in supraventricular arrhythmias","volume":"27","author":"Sweany","year":"1985","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.jemermed.2018.12.010_bib44","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1016\/0002-9149(89)90076-3","article-title":"Efficacy and safety of intravenous diltiazem for treatment of atrial fibrillation and atrial flutter. The Diltiazem-Atrial Fibrillation\/Flutter Study Group","volume":"63","author":"Salerno","year":"1989","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jemermed.2018.12.010_bib45","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/0002-8703(90)90176-X","article-title":"Acute management of paroxysmal atrioventricular junctional reentrant supraventricular tachycardia: pharmacologic strategies","volume":"120","author":"Viskin","year":"1990","journal-title":"Am Heart J"},{"key":"10.1016\/j.jemermed.2018.12.010_bib46","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1177\/1060028013512473","article-title":"Intravenous metoprolol versus diltiazem for rate control in noncardiac nonthoracic postoperative atrial fibrillation","volume":"48","author":"Personett","year":"2014","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.jemermed.2018.12.010_bib47","first-page":"163","article-title":"New treatment of atrial fibrillation","volume":"164","author":"Herbert","year":"1996","journal-title":"West J Med"},{"key":"10.1016\/j.jemermed.2018.12.010_bib48","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.resuscitation.2004.04.001","article-title":"International EMS systems: France","volume":"63","author":"Adnet","year":"2004","journal-title":"Resuscitation"},{"key":"10.1016\/j.jemermed.2018.12.010_bib49","first-page":"165","article-title":"Safety and efficacy of vernakalant for acute cardioversion of atrial fibrillation: an update","volume":"9","author":"Tsuji","year":"2013","journal-title":"Vasc Health Risk Manag"},{"key":"10.1016\/j.jemermed.2018.12.010_bib50","first-page":"989","article-title":"A comparative study on the efficacy and safety of intravenous esmolol, amiodarone and diltiazem for controlling rapid ventricular rate of patients with atrial fibrillation during anesthesia period","volume":"38","author":"Shen","year":"2010","journal-title":"Zhonghua Xin Xue Guan Bing Za Zhi"},{"key":"10.1016\/j.jemermed.2018.12.010_bib51","doi-asserted-by":"crossref","first-page":"1859","DOI":"10.1253\/circj.CJ-10-0023","article-title":"Prospective comparative study of intravenous cibenzoline and disopyramide therapy in the treatment of paroxysmal atrial fibrillation after cardiovascular surgery","volume":"74","author":"Komatsu","year":"2010","journal-title":"Circ J"},{"key":"10.1016\/j.jemermed.2018.12.010_bib52","first-page":"840615","article-title":"management of atrial fibrillation in critically ill patients","volume":"2014","author":"Arrigo","year":"2014","journal-title":"Crit Care Res Pract"},{"key":"10.1016\/j.jemermed.2018.12.010_bib53","doi-asserted-by":"crossref","first-page":"1833","DOI":"10.1053\/euhj.1999.1747","article-title":"Conversion of recent-onset paroxysmal atrial fibrillation to normal sinus rhythm: the effect of no treatment and high dose amiodarone \u2014 a randomized, placebo-controlled study","volume":"20","author":"Cotter","year":"1999","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jemermed.2018.12.010_bib54","doi-asserted-by":"crossref","first-page":"191","DOI":"10.2147\/DHPS.S48640","article-title":"Hyperacute drug-induced hepatitis with intravenous amiodarone: case report and review of the literature","volume":"5","author":"Nasser","year":"2013","journal-title":"Drug Healthc Patient Saf"},{"key":"10.1016\/j.jemermed.2018.12.010_bib55","first-page":"e225","article-title":"Acute amiodarone syndrome after a single intravenous amiodarone bolus","volume":"53","author":"Ng","year":"2012","journal-title":"Singapore Med J"},{"key":"10.1016\/j.jemermed.2018.12.010_bib56","doi-asserted-by":"crossref","first-page":"H2003","DOI":"10.1152\/ajpheart.00404.2004","article-title":"Duration of diastole and its phases as a function of heart rate during supine bicycle exercise","volume":"287","author":"Chung","year":"2004","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1016\/j.jemermed.2018.12.010_bib57","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/1476-7120-6-15","article-title":"Diastolic time \u2013 frequency relation in the stress echo lab: filling timing and flow at different heart rates","volume":"6","author":"Bombardini","year":"2008","journal-title":"Cardiovasc Ultrasound"},{"key":"10.1016\/j.jemermed.2018.12.010_bib58","first-page":"2609","article-title":"Diastolic heart failure: challenges of diagnosis and treatment","volume":"69","author":"Gutierrez","year":"2004","journal-title":"Am Fam Physician"},{"key":"10.1016\/j.jemermed.2018.12.010_bib59","doi-asserted-by":"crossref","first-page":"H2363","DOI":"10.1152\/ajpheart.01125.2011","article-title":"Frequency-dependent left ventricular performance in women and men","volume":"302","author":"Wainstein","year":"2012","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1016\/j.jemermed.2018.12.010_bib60","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1016\/j.mehy.2013.09.002","article-title":"Every patient with atrial fibrillation has his (her) own optimal heart rate","volume":"81","author":"Liu","year":"2013","journal-title":"Med Hypotheses"},{"key":"10.1016\/j.jemermed.2018.12.010_bib61","first-page":"201","article-title":"A comparison of verapamil and digoxin for heart rate control in atrial fibrillation","volume":"2","author":"Moghadam","year":"2012","journal-title":"Adv Pharm Bull"},{"key":"10.1016\/j.jemermed.2018.12.010_bib62","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1253\/circj.CJ-13-0289","article-title":"Acute rate control in atrial fibrillation with left ventricular dysfunction","volume":"77","author":"Momomura","year":"2013","journal-title":"Circ J"},{"key":"10.1016\/j.jemermed.2018.12.010_bib63","doi-asserted-by":"crossref","first-page":"86","DOI":"10.4250\/jcu.2009.17.3.86","article-title":"Therapeutic strategies for diastolic dysfunction: a clinical perspective","volume":"17","author":"Ha","year":"2009","journal-title":"J Cardiovasc Ultrasound"},{"key":"10.1016\/j.jemermed.2018.12.010_bib64","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1186\/1476-7120-9-36","article-title":"Abnormal shortened diastolic time length at increasing heart rates in patients with abnormal exercise-induced increase in pulmonary artery pressure","volume":"9","author":"Bombardini","year":"2011","journal-title":"Cardiovasc Ultrasound"},{"key":"10.1016\/j.jemermed.2018.12.010_bib65","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1016\/0002-9149(89)90141-0","article-title":"Esmolol versus verapamil in the acute treatment of atrial fibrillation or atrial flutter","volume":"63","author":"Platia","year":"1989","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jemermed.2018.12.010_bib66","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1016\/j.jacc.2003.11.032","article-title":"The Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) study: approaches to control rate in atrial fibrillation","volume":"43","author":"Olshansky","year":"2004","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jemermed.2018.12.010_bib67","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1093\/europace\/eun302","article-title":"Acute beta-adrenoceptor blockade improves efficacy of ibutilide in conversion of atrial fibrillation with a rapid ventricular rate","volume":"11","author":"Fragakis","year":"2009","journal-title":"Europace"},{"key":"10.1016\/j.jemermed.2018.12.010_bib68","first-page":"1012","article-title":"New insights into the mechanisms and management of atrial fibrillation","volume":"167","author":"Khairy","year":"2002","journal-title":"CMAJ"},{"key":"10.1016\/j.jemermed.2018.12.010_bib69","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/S0733-8651(03)00111-5","article-title":"Pharmacological rate control of atrial fibrillation","volume":"22","author":"Tamaritz","year":"2004","journal-title":"Cardiol Clin"},{"key":"10.1016\/j.jemermed.2018.12.010_bib70","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1016\/0002-8703(93)91053-H","article-title":"Combined use of esmolol and digoxin in the acute treatment of atrial fibrillation or flutter","volume":"126","author":"Shettigar","year":"1993","journal-title":"Am Heart J"},{"key":"10.1016\/j.jemermed.2018.12.010_bib71","first-page":"1","article-title":"Beta-blockade and A1-adenosine receptor agonist effects on atrial fibrillatory rate and atrioventricular conduction in patients with atrial fibrillation","volume":"7","author":"Corino","year":"2013","journal-title":"Europace"},{"key":"10.1016\/j.jemermed.2018.12.010_bib72","doi-asserted-by":"crossref","first-page":"347","DOI":"10.2165\/11631590-000000000-00000","article-title":"Clinical pharmacokinetics and therapeutic efficacy of esmolol","volume":"51","author":"Wiest","year":"2012","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.jemermed.2018.12.010_bib73","first-page":"212","article-title":"Clinical rationale for the use of an ultra-short acting beta-blocker: esmolol","volume":"33","author":"Barbiar","year":"1995","journal-title":"Int J Clin Pharmacol Ther"},{"key":"10.1016\/j.jemermed.2018.12.010_bib74","doi-asserted-by":"crossref","first-page":"109","DOI":"10.2165\/11208210-000000000-00000","article-title":"Esmolol: a review of its use in the short-term treatment of tachyarrhythmias and the short-term control of tachycardia and hypertension","volume":"72","author":"Garnock-Jones","year":"2012","journal-title":"Drugs"},{"key":"10.1016\/j.jemermed.2018.12.010_bib75","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1007\/s40256-013-0035-2","article-title":"The effectiveness and safety of landiolol hydrochloride, an ultra-short-acting \u03b21-blocker, in postoperative patients with supraventricular tachyarrhythmias: a multicenter, randomized, double-blind, placebo-controlled study","volume":"13","author":"Taenaka","year":"2013","journal-title":"Am J Cardiovasc Drugs"},{"key":"10.1016\/j.jemermed.2018.12.010_bib76","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1007\/s12325-014-0111-2","article-title":"Impacts of patients characteristics on the effectiveness of landiolol in AF\/AFL patients complicated with LV dysfunction: subgroup analysis of the J-Land study","volume":"31","author":"Kinugawa","year":"2014","journal-title":"Adv Ther"},{"key":"10.1016\/j.jemermed.2018.12.010_bib77","doi-asserted-by":"crossref","first-page":"254","DOI":"10.2459\/JCM.0b013e328365b554","article-title":"Ranolazine for the prevention or treatment of atrial fibrillation: a systematic review","volume":"15","author":"Dagres","year":"2014","journal-title":"J Cardiovasc Med"},{"key":"10.1016\/j.jemermed.2018.12.010_bib78","doi-asserted-by":"crossref","first-page":"1975","DOI":"10.1016\/j.jacc.2011.07.036","article-title":"Cardiovascular outcomes in the AFFIRM trial: an assessment of individual antiarrhythmic drug therapies compared to rate control using propensity score matched analyses","volume":"58","author":"Saksena","year":"2011","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jemermed.2018.12.010_bib79","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1007\/s10840-008-9290-6","article-title":"Efficacy and safety of dofetilide in patients with atrial fibrillation and atrial flutter","volume":"23","author":"Banchs","year":"2008","journal-title":"J Interv Card Electrophysiol"},{"key":"10.1016\/j.jemermed.2018.12.010_bib80","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1253\/circj.CJ-12-0142","article-title":"Intravenous infusion of ultra-short-acting \u00df-blocker for postoperative atrial fibrillation is the one of choice","volume":"76","author":"Akaishi","year":"2012","journal-title":"Circ J"},{"key":"10.1016\/j.jemermed.2018.12.010_bib81","doi-asserted-by":"crossref","first-page":"169","DOI":"10.2310\/8000.2012.110591","article-title":"Use of rate control medication before cardioversion of recent-onset atrial fibrillation or flutter in the emergency department is associated with reduced success rates","volume":"14","author":"Blecher","year":"2012","journal-title":"CJEM"},{"key":"10.1016\/j.jemermed.2018.12.010_bib82","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1016\/j.amjcard.2007.11.067","article-title":"Rhythm versus rate control in the contemporary management of atrial fibrillation in-hospital","volume":"101","author":"Allen Lapointe","year":"2008","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jemermed.2018.12.010_bib83","doi-asserted-by":"crossref","first-page":"27","DOI":"10.2478\/v10153-011-0085-7","article-title":"Effect of selective beta-blockade with bisoprolol in the treatment of recent-onset atrial fibrillation","volume":"54","author":"Negreva","year":"2012","journal-title":"Folia Med (Plovdiv)"},{"key":"10.1016\/j.jemermed.2018.12.010_bib84","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1056\/NEJMoa1001337","article-title":"Lenient versus strict rate control in patients with atrial fibrillation","volume":"362","author":"Van Gelder","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jemermed.2018.12.010_bib85","first-page":"S10","article-title":"Pharmacological management of atrial fibrillation: established and emerging options","volume":"15","author":"Kalus","year":"2009","journal-title":"J Manag Care Pharm"},{"key":"10.1016\/j.jemermed.2018.12.010_bib86","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1186\/1756-0500-6-94","article-title":"Meta-analysis of vernakalant on conversion of atrial fibrillation","volume":"6","author":"Yan","year":"2013","journal-title":"BMC Res Notes"},{"key":"10.1016\/j.jemermed.2018.12.010_bib87","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.7326\/0003-4819-139-12-200312160-00011","article-title":"Management of newly detected atrial fibrillation: a clinical practice guideline from the American Academy of Family Physicians and the American College of Physicians","volume":"139","author":"Snow","year":"2003","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jemermed.2018.12.010_bib88","doi-asserted-by":"crossref","first-page":"S32","DOI":"10.1097\/00005344-199100176-00007","article-title":"Antiarrhythmic treatment of atrial arrhythmias","volume":"17","author":"Kulbertus","year":"1991","journal-title":"J Cardiovasc Pharmacol"},{"key":"10.1016\/j.jemermed.2018.12.010_bib89","first-page":"431","article-title":"Plasma timolol levels after oral and intravenous administration","volume":"14","author":"Else","year":"1978","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.jemermed.2018.12.010_bib90","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1510\/icvts.2009.212837","article-title":"Postoperative administration of landiolol hydrochloride for patients with supraventricular arrhythmia: the efficacy of sustained intravenous infusion at a low dose","volume":"9","author":"Wariishi","year":"2009","journal-title":"Interact Cardiovasc Thorac Surg"},{"key":"10.1016\/j.jemermed.2018.12.010_bib91","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1017\/S148180350001441X","article-title":"Myth: intravenous amiodarone is safe in patients with atrial fibrillation and Wolff-Parkinson-White syndrome in the emergency department","volume":"7","author":"Tijunelis","year":"2005","journal-title":"CJEM"}],"container-title":["The Journal of Emergency Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0736467918311995?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0736467918311995?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T16:41:56Z","timestamp":1760028116000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0736467918311995"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,3]]},"references-count":91,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2019,3]]}},"alternative-id":["S0736467918311995"],"URL":"https:\/\/doi.org\/10.1016\/j.jemermed.2018.12.010","relation":{},"ISSN":["0736-4679"],"issn-type":[{"value":"0736-4679","type":"print"}],"subject":[],"published":{"date-parts":[[2019,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Esmolol Compared with Amiodarone in the Treatment of Recent-Onset Atrial Fibrillation (RAF): An Emergency Medicine External Validity Study","name":"articletitle","label":"Article Title"},{"value":"The Journal of Emergency Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jemermed.2018.12.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}